首页> 外文期刊>Clinical microbiology and infection: European Society of Clinical Microbiology and Infectious Diseases >Prevalence and spread of extended-spectrum p-lactamase-producing Enterobacteriaceae in Europe
【24h】

Prevalence and spread of extended-spectrum p-lactamase-producing Enterobacteriaceae in Europe

机译:在欧洲生产广谱对内酰胺酶的肠杆菌科细菌的流行和传播

获取原文
获取原文并翻译 | 示例
           

摘要

Extended-spectrum beta-lactamases (ESBLs) represent a major threat among resistant bacterial isolates. The first types described were derivatives of the TEM-1, TEM-2 and SHV-1 enzymes during the 1980s in Europe, mainly in Klebsiella pneumoniae associated with nosocomial outbreaks. Nowadays, they are mostly found among Escherichia coli isolates in community-acquired infections, with an increasing occurrence of CTX-M enzymes. The prevalence of ESBLs in Europe is higher than in the USA but lower than in Asia and South America. However, important differences among European countries have been observed. Spread of mobile genetic elements, mainly epidemic plasmids, and the dispersion of specific clones have been responsible for the increase in ESBL-producing isolates, such as those with TEM-4, TEM-24, TEM-52, SHV-12, CTX-M-9, CTX-M-14, CTX-M-3, CTX-M-15 and CTX-M-32 enzymes.
机译:广谱β-内酰胺酶(ESBLs)代表了耐药菌中的主要威胁。所描述的第一类是1980年代欧洲的TEM-1,TEM-2和SHV-1酶的衍生物,主要发生在与医院内暴发有关的肺炎克雷伯菌中。如今,它们大多在社区获得性感染的大肠杆菌分离物中发现,并且CTX-M酶的发生率不断增加。欧洲ESBL的患病率高于美国,但低于亚洲和南美。但是,已经观察到欧洲国家之间存在重要差异。流动遗传元件(主要是流行质粒)的散布以及特定克隆的散布导致产生ESBL的分离株增加,例如带有TEM-4,TEM-24,TEM-52,SHV-12,CTX- M-9,CTX-M-14,CTX-M-3,CTX-M-15和CTX-M-32酶。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号